Teladoc Health to Announce Fourth Quarter 2025 Financial Results

Rhea-AI Summary

Teladoc Health (NYSE: TDOC) will release its fourth quarter 2025 results on Wednesday, February 25, 2026, after market close, and will host a conference call the same day at 5:00 p.m. ET. Investors can access the call by phone, global dial-in, or a live audio webcast.

A replay will be available via webcast shortly after the call and remain online for approximately 90 days.

News Market Reaction – TDOC

+5.92%

1 alert

+5.92% News Effect

On the day this news was published, TDOC gained 5.92%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings period: Fourth quarter 2025 Earnings release date: February 25, 2026 Conference call time: 5:00 p.m. ET +5 more

8 metrics

Earnings period Fourth quarter 2025 Results scheduled for release

Earnings release date February 25, 2026 Q4 2025 results after market close

Conference call time 5:00 p.m. ET Q4 2025 earnings call

U.S. dial-in number 1-833-470-1428 Access for U.S. participants to earnings call

Access code 330912 Code required to join earnings conference call

Replay availability Approximately 90 days On-demand webcast of earnings call

52-week high $15.21 Pre-news trading range context

52-week low $4.86 Pre-news trading range context

Market Reality Check

Price: $4.65 Vol: Volume 9,883,310 is about...

normal vol

$4.65 Last Close

Volume Volume 9,883,310 is about 1.4x the 20-day average of 7,041,518 shares. normal

Technical Shares at $4.73, trading below the 200-day MA of $7.51 and well under the $15.21 52-week high.

Peers on Argus

TDOC fell 3.91% while key peers were mixed: GDRX up 6.22%, SDGR, OMCL, PHR, and ...

1 Up

TDOC fell 3.91% while key peers were mixed: GDRX up 6.22%, SDGR, OMCL, PHR, and CERT modestly down. Only one sector peer (EVH) appeared in momentum scans, moving up, suggesting stock-specific pressure rather than a broad sector move.

Common Catalyst Some peers, such as OMCL, also issued earnings-related announcements, but sector-wide momentum signals were limited.

Historical Context

5 past events · Latest: Jan 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	Product expansion news	Positive	-2.8%	Launch of enhanced 24/7 Care nationwide expanding virtual urgent care capabilities.
Jan 05	Investor conference	Neutral	+3.3%	CEO presentation at J.P. Morgan Healthcare Conference with webcast access for investors.
Nov 26	Investor conference	Neutral	+1.9%	CEO participation in Piper Sandler Healthcare Conference with webcast replay available.
Nov 18	Partnership news	Positive	+3.7%	Integration of TytoCare home diagnostics with Teladoc primary and urgent care programs.
Nov 06	Equity compensation	Neutral	-1.2%	Employee inducement award of RSUs and PSUs for new Chief Technology Officer.

Pattern Detected

Recent news often saw muted or negative next-day moves, even on operationally positive updates.

Recent Company History

Over the last few months, Teladoc Health issued several operational and corporate updates. A Nov 6, 2025 inducement award announcement (RSUs/PSUs) and the Nov 18, 2025 TytoCare integration news were followed by modest price reactions. Subsequent investor conference participations on Nov 26, 2025 and Jan 5, 2026 produced small positive moves. However, the enhanced 24/7 Care launch on Jan 12, 2026 coincided with a negative reaction. Today’s earnings-date notice fits this pattern of informational releases around strategic initiatives and investor-facing events.

Market Pulse Summary

The stock moved +5.9% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +5.9% in the session following this news. A strong positive reaction aligns with the importance of upcoming earnings for a stock trading well below its 52-week high and under its 200-day MA. Past news showed mixed immediate reactions, even when updates were operationally positive. If gains followed this announcement, investors may have been positioning ahead of the February 25, 2026 release, but attention would likely remain on execution, insider activity, and any capital or strategy updates shared with the results.

AI-generated analysis. Not financial advice.

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.

Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=95347. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612

FAQ

When will Teladoc (TDOC) release fourth quarter 2025 results?

Teladoc will release Q4 2025 results on Wednesday, February 25, 2026, after the market closes. According to Teladoc, the announcement and accompanying conference call occur the same day to review financial results and provide investor commentary.

What time is Teladoc's (TDOC) Q4 2025 earnings conference call on February 25, 2026?

The conference call is scheduled for 5:00 p.m. ET on February 25, 2026. According to Teladoc, the call follows the after‑market release and will include management's review of the fourth quarter results.

How can investors access Teladoc's (TDOC) February 25, 2026 earnings call?

Investors can join by dialing 1-833-470-1428 (U.S.) with access code 330912 or use global dial‑ins via the provided link. According to Teladoc, a live audio webcast will also be available on the investor website.

Will Teladoc (TDOC) provide a replay of the Q4 2025 earnings call?

Yes. A replay will be available via webcast shortly after the call and remain accessible for about 90 days. According to Teladoc, the replay is hosted on the same investor events web page used for the live webcast.

Where can investors find Teladoc's (TDOC) Q4 2025 webcast and materials?

The live audio webcast and related materials will be posted on Teladoc's investor events page. According to Teladoc, the webcast link provides access to the live call and the on‑demand replay for roughly 90 days.